» Articles » PMID: 39208300

Religious Beliefs and Practices Toward HPV Vaccine Acceptance in Islamic Countries: A Scoping Review

Overview
Journal PLoS One
Date 2024 Aug 29
PMID 39208300
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite the availability of effective HPV vaccines, their acceptance in Islamic countries is often influenced by religious beliefs, practices, and misconceptions.

Objective: This review aimed to identify the current literature on the religious beliefs and any misconceptions toward HPV vaccine acceptance within the Organisation of Islamic Cooperation (OIC) countries.

Method: Using key terms, a systematic search in MEDLINE/PubMed, Embase, and CINAHL yielded 23 studies that met the inclusion and exclusion criteria. The scope of this review included all research articles published in English until October 31, 2023. A form based on the aim of the study was developed and used to extract the data.

Results: The review highlights the complexity of the relationship between religious beliefs and HPV vaccine uptake. The findings reveal significant objections among a number of Muslims. Some of them believe vaccines lead to infertility and sexual promiscuity, defy religious norms, are a sneaky way to inject good Muslims with haram ingredients, and are an abandonment of righteous principles in general.

Conclusions: Vaccine hesitancy is a result of doubts regarding the vaccine's safety, necessity, and compatibility with religious beliefs. It is recommended to encourage HPV vaccine uptake in Islamic countries by using public health strategies that adopt a holistic approach that incorporates religious, cultural, and social aspects.

Citing Articles

Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake.

Sendekie A, Abate B, Adamu B, Tefera A, Mekonnen K, Ashagrie M Front Public Health. 2025; 13:1507832.

PMID: 39916703 PMC: 11798796. DOI: 10.3389/fpubh.2025.1507832.


Knowledge, Awareness, and Attitudes Towards HPV and Its Vaccination Among Women in the Medina Region: A Cross-Sectional Study.

Tobaiqi M, Albouq R, Ban A, Alharbi A, Alhejaili R, Alrefaei H Healthcare (Basel). 2024; 12(23).

PMID: 39684961 PMC: 11641522. DOI: 10.3390/healthcare12232339.

References
1.
Shdefat S, Al Awar S, Osman N, Khair H, Sallam G, Elbiss H . Health Care System View of Human Papilloma Virus (HPV) Vaccine Acceptability by Emirati Men. Comput Math Methods Med. 2022; 2022:8294058. PMC: 8816567. DOI: 10.1155/2022/8294058. View

2.
Garland S, Hernandez-Avila M, Wheeler C, Perez G, Harper D, Leodolter S . Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007; 356(19):1928-43. DOI: 10.1056/NEJMoa061760. View

3.
Balogun F, Omotade O . "She must have been sleeping around"…: Contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria. PLoS One. 2018; 13(9):e0203950. PMC: 6141096. DOI: 10.1371/journal.pone.0203950. View

4.
Grandahl M, Paek S, Grisurapong S, Sherer P, Tyden T, Lundberg P . Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PLoS One. 2018; 13(2):e0193054. PMC: 5814087. DOI: 10.1371/journal.pone.0193054. View

5.
Momenimovahed Z, Mazidimoradi A, Maroofi P, Allahqoli L, Salehiniya H, Alkatout I . Global, regional and national burden, incidence, and mortality of cervical cancer. Cancer Rep (Hoboken). 2022; 6(3):e1756. PMC: 10026270. DOI: 10.1002/cnr2.1756. View